Abstract
Micro‐ and nanoparticles prepared from the biodegradable and biocompatible polymers poly(lactide‐co‐glycolide) (PLGA) and polymethylmethacrylate (PMMA) have been successfully used as immunopotentiating antigen delivery systems. In our study, this approach was used to improve polyclonal antibody production to clenbuterol (CBL), a model hapten. PLGA and PMMA nanoparticles were loaded with either CBL alone or with a clenbuterol‐transferrin conjugate (CBL—Tfn) and administered subcutaneously to mice. PLGA nanoparticles were administered with or without the saponin adjuvant Quil A. The anti‐CBL titres present in experimental sera were determined by an enzyme immunoassay (ELISA). CBL‐Tfn‐loaded PLGA nanoparticles co‐administered with Quil A had obvious advantages immunologically over the currently used method of raising antibodies to CBL (the positive control). The combined adjuvanticity of Quil A and PLGA nanoparticles resulted in a positive response in all four of the mice tested and in higher antibody titres than were seen in the positive control group. Furthermore, the sustained release of immunogen from the nanoparticles permitted a reduction in immunizing frequency over the 15‐week study period.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
